Ligand profile
CHEMBL1191
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_03130 — Dihydropteroate synthase type-1
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1191- UniProt (similar protein)
P0AC13- Target protein
- KP13_03130
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 98.0
- −1 ≤ LogP ≤ 5 1.23
- MW ≤ 500 Da 270.3
- LogP ≤ 5 1.23
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 98.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1
InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)
VACCAVUAMIDAGB-UHFFFAOYSA-NVACCAVUAMIDAGB-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Mechanism
- Bacterial dihydropteroate synthase inhibitor
- Binding sites
- PF00809
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1191 →
- UniProt UniProt P0AC13 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1191”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03130.
PDB 47
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 25
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).